))
Episode 5: Professor Roger Greenhalgh
Manage episode 324723156 series 2984480
Conteúdo fornecido por Ramon Varcoe, Peter Schneider, Andrew Holden, Ramon Varcoe, Peter Schneider, and Andrew Holden. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Ramon Varcoe, Peter Schneider, Andrew Holden, Ramon Varcoe, Peter Schneider, and Andrew Holden ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Professor Roger Greenhalgh has been instrumental in defining when and how to treat aortic aneurysm disease, through decades of clinical trial research that has led that line of scientific inquiry. Such trials include the UK Small Aneurysms trial, EVAR 1, EVAR 2 and IMPROVE which together have formed the foundational evidence for clinical practice guidelines. This interview includes the back story of how they came to be, as well as exploring the world-famous Charing Cross Symposium, now in its 44th year, which has had to reinvent itself in the face of the COVID-19 pandemic. Roger also shares many wonderfully entertaining personal anecdotes in this most delightful interview.
8 episódios
Compartilhar
